Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus.
Moloney
Fiona
F
Nutrigenomics Research Group, Department of Clinical Medicine, Trinity Centre for Health Sciences, Dublin, Ireland.
Yeow
Toh-Peng
TP
Mullen
Anne
A
Nolan
John J
JJ
Roche
Helen M
HM
D000704:Analysis of Variance; D019540:Area Under Curve; D001786:Blood Glucose / Q000187:drug effects* / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000378:metabolism* / Q000517:prevention & control; D019587:Dietary Supplements; D004311:Double-Blind Method; D005215:Fasting; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007249:Inflammation / Q000097:blood*; D007328:Insulin / Q000378:metabolism*; D044243:Linoleic Acids, Conjugated / Q000008:administration & dosage* / Q000627:therapeutic use; D008074:Lipoproteins / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
D001786:Blood Glucose; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D007328:Insulin; D044243:Linoleic Acids, Conjugated; D008074:Lipoproteins